IDF Europe represents 72 national diabetes associations across 45 countries in the European Region. IDF Europe acknowledges the importance of the Medical Devices Regulation in ensuring the quality, safety and performance of medical devices that are placed on the EU market.
IDF
International Diabetes Federation Europe
NGO · Belgium · EU Transparency Register 80267287489-88
3
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #281 by legislative files engaged — a count of participation, not a measure of influence.
7.8
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
5
EP accreditations
as declared to the register
2011
in the register since
Declares membership of
- IDF Europe is member of:
- EPHA - European Public Health Alliance
- EPF - European Patients Forum
- ESWI - European Scientific Working group on Influenza
- EMA - European Medicines Agency
- ECDA - European Chronic Disease Alliance
- EU Platform for action on diet, physical activity and health
- EU Platform on Mental Health and Covid-19
- EU Health Coalition
- EU Health Policy Forum
- EASD - European Association for the Study of Diabetes (Attendance to EASD General Assembly), transnational member of IDF
- SFD - Société Francophone du Diabète, transnational member of IDF
- and 1 more
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Registered as
- International Diabetes Federation European Region (IDF Europe)
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track International in PolicySpeak: request access →
Work at International Diabetes Federation Europe? so we know who speaks for it.
Their record over time
International Diabetes Federation Europe filed 3 positions between 6 Oct 2025 and 28 Jul 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2025 · 1 filed2026 · 2 filed
What they argued
Medical devices have become an essential component of diabetes management. Yet, despite their increasing availability, many of the 34 million people living with diabetes in the EU do not achieve their treatment targets. This highlights the need to foster more innovation and facilitate the introduction of new devices that better meet people's needs.
For the 34 million people living with diabetes in the EU, biotechnology has the potential to transform prevention, treatment and long-term care. Advances such as next-generation insulins, cell and gene-based therapies and other biotechnology-derived medicines could significantly improve health outcomes and quality of life. Europe already has the scientific excellence to lead this transformation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- IDEE ECONOMICHE www.idee-economiche.it · 2 files in common
- Wirtschaftskammer Österreich · 2 files in common
- BEUC - The European Consumer Organisation · 2 files in common
- MedTech Europe · 2 files in common
- EFPIA · 2 files in common
Showing 5 of 44.
Is this your organization?
Everything on this page comes from International Diabetes Federation Europe’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.